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Abstract
Background: Remote monitoring of cardiac implantable electronic devices (CIEDs) has demonstrated substantial
benefits. Treatment guidelines have therefore endorsed its use and is being increasingly adopted in the clinical
setting, but the level of satisfaction they convey remains still unknown. We developed and validated a
questionnaire to measure patient satisfaction with remote monitoring using Medtronic CareLink® Network and
assessed its internal reliability and dimensional validity.
Methods: After a thorough literature review, cognitive debriefing of 18 patients, and an expert panel discussion, a
30-item instrument was proposed and grouped into 5 dimensions (items): 1- Information on cardiac condition (3),
2- Device convenience (3), 3- Transmission process (6), 4- Satisfaction with medical monitoring (8), and 5- General
opinions (10). Correlation with the visual analog scale (VAS), overall health related quality of life (HRQoL) measured
by the EuroQoL-5D accompanied by the VAS as well as with the Medical Outcomes Study (MOS) SF-36 were
assessed. Psychometric properties, exploratory factor analysis and a second order confirmatory factor analysis (a
hierarchical CFA with a general common factor explaining the relations between the first order common factors,
See Figure 1) were estimated. Models were assessed based on item loading size, sign and statistical significance,
and goodness-of-fit statistics.
Results: A total of 186 patients (77% male) with a mean age of 66.03 (SD = 13.94) years were assessed. 48% had
implantable cardioverter-defibrillators, 24% had pacemakers, and 29% had cardiac resynchronization therapy
devices. An overall Cronbach’s α = 0.893 was achieved, with acceptable reliabilities for isolated dimensions.
Correlations with corresponding VAS scales were meaningful and significant (p < 0.01). The second order factor
solution yielded good goodness-of-fit indexes (χ2/df = 1.44, CFI = 0.96, TLI = 0.95, RMSEA = 0.05). Satisfaction with
remote monitoring was not related to HRQoL (r < 0.05), except for the correlation between the SF-36 mental
component and the information on cardiac condition dimension (r = 0.263, p < 0.001).
Conclusions: The 30-item questionnaire showed good reliability and validity to assess satisfaction with remote
monitoring in patients with CIEDs.
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Background
Technology available for managing cardiac implantable
electronic devices (CIED) has advanced considerably. In
this sense, remote monitoring (RM) represents a com-
plement to routine in-office care that provides access to
a tremendous wealth of information recorded and stored
by CIEDs such as device performance, including history
of cardiac arrhythmias, battery and lead parameters
without face-to-face interaction. Remote monitoring
enables remote feedback from device to physician and
allows for continuous remote monitoring, which im-
proves patient safety and care by allowing any device
problems to be detected immediately [1]. In addition to
clinical benefits, RM has been shown to allow for longer
intervals between in-office visits and a shorter visit dur-
ation as querying the device is no longer necessary, thus
lightening the burden of in-hospital follow-up of patients
with implanted devices, with the consequent cost reduc-
tion [2, 3] Thanks to demonstrated substantial benefits,
treatment guidelines have endorsed its use for all eligible
patients and RM is being increasingly adopted in the
clinical setting [4].
Despite the existing clinical and economic evidence
available, patient reported outcomes have received little
attention, even though they are expected to play a more
prominent role in assessing performance and determining
the comparative effectiveness of treatment alternatives, in
part because of a growing emphasis on patient-centered
care and value-based procurement initiatives.
In particular, patient satisfaction represents an import-
ant measure of the extent to which a patient is satisfied
with all aspects of healthcare delivery that are of rele-
vance to health, which could be related with the quality
of care patients receive. It has been shown that patient
satisfaction affects patients’ health-related decisions and
treatment-related behaviors (like appropriate use of ser-
vices, correct medication use or treatment continuation),
and consequently, impacting substantially the success of
treatment outcomes [5].
To date, few publications evaluating patient satisfac-
tion associated with RM of patient with CIEDs have
been published. Large registries like ALTITUDE and
PREDICT-RM did not include patient reported out-
comes [6, 7]; besides these registries, certain observa-
tional studies have considered measures of health status,
satisfaction and/or acceptation, remote patient monitor-
ing experiences, and preferences for follow-up but using
a self-designed questionnaire that did not undergo a
strict validation process [8–11]. There is currently a
European randomized controlled trial ongoing (RE-
MOTE-CIED) designed to examine the patient perspec-
tive of RM but it only covers patients with implantable
cardioverter-defibrillators (ICD) and cardiac resynchro-
nization therapy devices (CRT) [12].
Despite the increasing interest in patient opinions and
concerns, to date there is no validated questionnaire spe-
cifically designed to measure patient satisfaction with
CIED RM systems. We believe that patient satisfaction
measurement is not only a compromise with quality
management for health service providers [13] but also a
need towards identifying problematic users, and particu-
larly among those who do not make automated trans-
missions (like pacemaker users).
The aim of the present study was to develop a new
questionnaire with proven psychometric properties that
measures patient satisfaction with RM in patients with
CIEDs, focusing on a specific RM system, CareLink® Net-
work (Medtronic, Minneapolis, MN), currently used by
more than 1,300,000 patients from more than 1200 health
centers worldwide in about 80 different countries [14].
Methods
The present research was designed as an observational,
two-stage, cross-sectional, multicenter study to develop
a specific instrument for the measurement of patient sat-
isfaction with RM of CIED. Patients with implanted
pacemakers (PM), ICD, and CRT devices who had been
using CareLink® Network for at least 2 months before
recruitment were included. The study was conducted
under actual treatment conditions for their disorder in
clinical practice.
The Medtronic CareLink® Network is the Internet-
based remote monitoring service for patients with Med-
tronic implanted cardiac devices. It allows patients a
convenient timely connection to their clinic using the
person’s monitor/ smartphone/ tablet to collect and
transmit device data. A hand-held smart reader is used
to collect data from the implanted device. The smart
reader communicates with the monitor and, through a
software application, it transfers the data to the CareLink®
Network. All the information is recorded and reviewed by
the nurses through the online platform. In case there is a
critical event, the patient is called by the medical staff to
visit the physician (Figure 6 Additional file 3).
The study was performed following the Helsinki-
Tokyo-Venice guidelines for human research.
Development phase: study design and participants
The aim of the development phase was to create and de-
sign the VALIOSA questionnaire incorporating the pa-
tient perspective.
For that purpose, a thorough literature review and pa-
tient focus groups were conducted to identify relevant
contents and topics addressing treatment satisfaction
and patient management.
Two focus groups were held at two different hospitals.
The first one took place at Hospital Universitario de
Araba (Vitoria) with 10 patients and the other one at
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Hospital Infanta Leonor (Madrid) with 8 patients. Patients
were recruited at random from those with a scheduled
visit in the selected week and balancing for gender and
age. The topics discussed included symptoms and disease
burden, daily limitations, device-related discomfort, life-
style changes, impact on social relationships, family and
specialized support, and appropriate follow-up. Patient
contributions were summarized following a semantic re-
duction process by two independent content specialists.
As a result, a preliminary questionnaire of 52 items was
proposed.
This raw version underwent a discussion and semantic
refinement process by an expert panel consisting of four
cardiologists, one psychometrician and one pharmacist.
Redundant and inappropriate items were discarded and
replaced by equivalent items and was reduced to 37 items.
This initial set of 37 items comprised the following
RM aspects: information on monitor use, training and
convenience of monitor use, problems with the trans-
mission process, satisfaction with medical care and RM,
and benefits and impact on activities of daily living.
The reviewed version was administered to a pilot sam-
ple consisting of 10 patients to check comprehension
and acceptance, and the information gathered was used
to refine the items. The resulting version was composed
of 30 items grouped into 5 dimensions (number of items):
information (3), monitor convenience (3), monitor hand-
ling and transmission process (6), disease follow-up (7),
general impression and benefits (11). A panel composed
by 9 specialists (cardiologists, nurses and psychometri-
cians) assessed content validity, scoring item adequacy for
measuring each content dimension and the unidimen-
sional [15] and multidimensional [16] item-domain con-
gruence indexes were computed.
Validation phase: study design and participants
The aim of the validation phase was to administer the 30-
item version to a representative sample of patients to check
item fit to the proposed construct, check psychometric
properties of the preliminary questionnaire designed in
the development phase, and reduce the number of items
(if necessary) in accordance with the proposed construct.
Patients
Three samples of patients were recruited at 4 hospitals
in 3 regions of Spain. A pilot sample of 10 patients was
recruited to check item comprehension and to identify
possible response problems. Finally, a sample of 186
patients was recruited to measure psychometric proper-
ties. All patients had to meet selection criteria: being
older than 18 years of age, being implanted with a CIED,
having more than 2 months of experience using RM,
being able to understand and answer questionnaires in
Spanish, and having no cognitive impairment.
Sample size was determined based on the anticipated
number of dimensions, the number of items per dimen-
sion (3:1) [17, 18], the number of patients per item (4:1),
[19, 20] and the sample representativeness (n > 150) [21].
A sample size of 180 patients with complete information
was deemed necessary.
Psychometric properties of final version
Dimension and overall scale reliability (internal consistency)
was estimated by computing Cronbach’s alpha and 95%
confidence interval intra-class correlation coefficient (ICC)
for internal consistency.
To test the construct validity of the questionnaire, a
confirmatory factor analysis was performed including all
items, assuming a second order factor structure with
items as indicators of the proposed first order dimen-
sions and with all dimension loading in an overall satis-
faction second order dimension. The robust weighted
least squares estimation method was used.
The following psychometric properties were studied.
Feasibility: response time, floor-ceiling effect, and miss-
ing values distribution; Internal Consistency/Reliability:
Cronbach’s alpha, item correlations, adjusted item-total
correlation, ICC and omega [22]; Construct Validity:
Confirmatory factor analysis; Concurrent Validity: Correl-
ation between the new questionnaire (VALIOSA) and the
VAS measures; Convergent and construct Validity: Correl-
ation between similar/dissimilar dimensions of the VALIOSA,
MOS SF-36 dimensions and corresponding VAS measures.
Instruments
The final refined questionnaire, named VALIOSA (see
Additional files 1 & 2), was included in a clinical record
form along with questions about patient social and
demographic characteristics, relevant clinical informa-
tion, the MOS SF-36, and 6 VAS.
The VALIOSA questionnaire is a 30-item, self-completed
questionnaire measured on a 5-point Likert scale (0 = No,
nothing, 4 = Yes, a lot) to measure patient satisfaction with
RM. It is structured in 5 dimensions: 1- Information on
cardiac condition (3 items), 2- Device convenience (3
items), 3- Transmission process (6 items), 4- Satisfaction
with medical monitoring (8 items), and 5- General opin-
ions (10 items). Dimension scores are obtained by adding
item scores for that dimension and transforming the ob-
tained score to a 0–100 common metric. The rescaled
score is obtained using the following transformation:
Y 0 ¼ Yobs−Ymin
Ymax−Ymin
 100
Where Ymax =maximum dimension score, Ymin = 0
(minimum score dimension), Yobs = observed dimension
score (algebraic summation), and Y′ = transformed score.
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Scores for items 9, 10, 12, and 19 need to be reversed be-
fore summation. An overall score can be calculated by
averaging the dimension scores.
Additionally, five 15-cm VAS (0 = Completely unsatis-
fied, 10 = Completely satisfied), with 10 marks along the
scale, were used as convergent measures of the same
concepts contained in the dimensions. The HRQoL VAS
accompanying the EuroQoL-5D [23] was used to meas-
ure overall health related quality of life and as a distinct
measure from satisfaction. HRQoL was also measured
using the MOS SF-36 [24]. This is a generic instrument
measuring 8 dimensions arranged in 2 summary compo-
nents (physical and mental) using 36 items.
All analyses were performed using IBM SPSS 20,
AMOS 20, and Mplus 7.31 software.
Results
Development phase
Focus groups
Of the 18 participants in the 2 focus groups, 78% were
male, 56% had PM, and 44% had ICD. Mean age was 67.5
years (SD = 7.1, min. = 54, max. = 80), mean time since im-
plantation was 2.03 years (SD = 5.8, min. = 2months,
max. = 20 years), and mean use of CareLink® Network was
2.03 years (SD = 1.7, min. = 2months, max. = 5 years).
Most patients reported living a normal life for their
age, although they tried to avoid physical exertion. Some
reported they had adopted healthier habits (no smoking
or alcohol consumption) since diagnosis, although they
thought that other diseases (e.g., diabetes) need more
stringent care.
PM patients showed some distrust of the transmission
process. They wished they could have made the first
transmission under supervision at the hospital. One pa-
tient called in 20min after each manual transmission,
even if the modem beeped at the end. ICD patients felt
they had tight supervision by their nurse, even receiving
phone calls when transmission errors occurred or when
fluid retention was observed during regular monitoring.
Intervals between face-to-face visits were perceived as
too long. One patient visited the medical team bringing
sweets to keep in touch. Self-support groups were not
welcome, only the clinician was trusted for delivering in-
formation. Patients did not manifest any other needs or
concerns and the saturation for information was reached
in each focus group.
Validation phase
Sample description
A sample of 186 patients was recruited between 2014
and 2015; 53% at Hospital Universitario de Araba, 30%
at Hospital Infanta Leonor, 15% at Hospital Sant Pau,
and 3% at Hospital Universitario La Paz. On average, pa-
tients were 66.03 (SD = 13.94) years old, 77% were men,
48% had ICD, 29% had PM, and 24% had CRT devices.
Nearly 77% were experienced in the use of CareLink®
Network, and 23.3% were naïve to this RM system.
Other descriptive variables are presented in Table 1.
Acceptance and responsiveness
Most patients (78.5%) fully understood all items and left
no blank responses, while 14.5% left one item blank and
3.8% left two. Two patients were excluded, because they
did not answer any question or left more than 80%
blank. Items with the highest non-response rates were
item 11 (13%) about getting support for technical prob-
lems and item 12 (5%) about having trouble on holidays.
We assumed that these items were left blank due to in-
applicability. The full response rate was slightly lower
(75.8%) for the MOS SF-36.
Almost all items presented a unimodal skewed distri-
bution of responses across response categories with a
marked ceiling/floor effect (more than 50% of responses
in the extreme category), and only two items did not ob-
tain responses in both range extreme categories. Dimen-
sion average scores ranged within 82.0 and 91.4 with a
total average of 88.8 (see Table 2). Differences between
mean dimension scores were statistically significantly
(p < 0.05), except for Disease Information vs. Conveni-
ence (p = 0.97) and vs. Monitoring (p = 1.0).
Reliability
The overall scale reliability was good (α = 0.893, ω =
0.95) while dimension reliabilities were good for General
Opinions (α = 0.836, ω = 0.94) and acceptable for Con-
venience (α = 0.772, ω = 0.92), Monitoring (α = 0.614,
ω = 0.86), Information (α = 0.588, ω = 0.79), and Trans-
mission (α = 0.576, ω = .76) (see Table 2). Since the scale
is thought to be multidimensional, α may be underesti-
mating the true reliability and ω values should be con-
sidered more informative.
Validity
Construct validity
Content validity results showed that experts were able to
identify the different domains measured but with a rela-
tive overlap between medical care and overall benefits
dimensions (See Additional file 3).
Correlations between item scores fit the proposed sec-
ond order factor model with an acceptable goodness-of-
fit: χ2/df = 1.63, CFI = 0.94, TLI = 0.94, RMSEA = 0.064.
All first-order loadings were significant (except for item
19) as were second order loadings (see Fig. 1). However,
several modifications had to be incorporated into the
model. Item 8 loaded on the Convenience dimension,
item 14 showed cross-loading on the General Benefits
dimension, item 19 showed cross-loading on the Trans-
mission dimension, and items 9 and 10 exhibited a
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significant correlation between their error terms. After
accepting these additional specifications, the model pro-
vided a substantially better fit: χ2/df = 1.44, CFI = 0.96,
TLI = 0.95, RMSEA = 0.05.
Convergent validity
All dimensions significantly correlated (p < 0.01) with
the corresponding VAS measure, although Monitoring
tended to correlate more highly with Convenience,
Transmission, and General Opinions, while information
exhibited a similar correlation with all other VAS scales
(differences in correlation below 0.110 were not statisti-
cally significant).
Correlations with divergent measures, i.e., the two
MOS SF-36 HRQoL and with the HRQoL VAS measure,
were negligible (Tables 3 & 4), except for the correlation
Table 2 Summary and reliability estimates of the VALIOSA questionnaire by dimension
Dimension Initial
number
of items
Mean Standard
Deviation
Cronbach’s
Alpha
95% ICC Omega Items
Lower Upper
1. Disease Information 3 91.4 13.6 .588 .473 .682 .79 1, 2, 3
2. Convenience 3 93.1 12.2 .772 .707 .824 .92 4, 5, 6
3. Transmission 6 82.0 16.1 .576 .467 .669 .76 7, 8, 9, 10, 11, 12
4. Monitoring 7 90.1 10.7 .614 .521 .695 .86 13, 14, 15, 16, 17, 18, 19
5. General Benefits 11 86.8 14.2 .836 .797 .870 .94 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
Total Scale 30 88.8 9.9 .893 .866 .917 .96 1–30
ICC Intra-class correlation coefficient
Table 1 Sample description of social/demographic and clinical variables
Employment Status (%) Marital Status (%)
Working 13.6 Single 9.5
Homemaker 8.9 Married 75.0
Retired 59.2 Divorced 6.0s
Unemployed 2.4 Widowed 8.3
Disabled 16.0 Other 1.2
Education Level (%) Clinical (%)
None 8.1 ICD 47.8
Primary 45.3 PM 28.6
Secondary 12.2 CRT 23.6
Professional Degree 16.9
Higher 17.4
Risk Factors (%) Heart Disease
Hypertension 59.5 Ischemic 53.4
Hypercholesterolemia 53.7 Dilated cardiomyopathy (non-ischemic) 33.6
History of AFib 38.8 Valvular 6.9
Smoking 37.2 Brugada syndrome 2.3
Diabetes 28.1 Other 6.1
History of renal insufficiency 17.4 None 3.8
History of sudden death 8.3
Stroke 8.3
CareLink use (%) Sex (%)
Experienced 76.7 Women 23.0
First implantation: Naïve 21.0 Men 77.0
Replacement/upgrade: Naïve 2.3
Sample size (N) 186
ICD Implantable Cardioverter-Defibrillator, PM Pacemaker, CRT Cardiac Resynchronization Therapy device
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between the General Opinions dimension and the
HRQoL VAS measure (r = 0.157, p < 0.05); while the
HRQoL VAS measure correlated more with the Physical
component (r = 0.550) than with Mental component (r =
0.272).
Known groups validity
VALIOSA dimensions were shown to be sensitive between
different types of patients. Significant differences were
found in the dimension mean scores between patients
depending on the type of implanted device (F2,179 = 14.0,
p < 0.001), with no interaction with the dimension score
factor (F8,716 = 1.09, p = 0.368). Overall, patients with PM
were significantly more dissatisfied than those with ICD
(d = − 6.8, p < 0.001) and CRT devices (d = − 9.3, p <
0.001), but the latter did not differ from one another
(d = 2.4; p = 0.477). This pattern was repeated for all di-
mensions (Fig. 2), except for Convenience, where ICD
and PM patients did not reach significance (d = − 4.7,
p = 0.078).
No significant differences were found in mean dimen-
sion scores between patients based on their experience
with CareLink® Network (F2,163 = 0.77, p = 0.462), al-
though initial implantation patients naïve to CareLink®
Network (M = 87.2) were slightly less satisfied than
experienced users (M = 89.0) and replacement patients
naïve to CareLink® Network (M = 92.3).
Significant differences were found in mean dimension
scores between patients from different hospitals (F3,171 =
3.65, p = 0.014) with an interaction term close to signifi-
cance (F12,684 = 1.68, p = 0.068), with average satisfaction
at one of the treatment sites significantly worse than the
others. After excluding that site from the analysis, more
statistically significant differences were found (which
could be explained by additional information received
from the sites).
Although small, a significant correlation was found be-
tween patient age and the Health Monitoring dimension
(r = 0.183; p = 0.013), but not for the remaining dimen-
sions nor for the overall score.
Discussion
To our knowledge, this is the first validated question-
naire developed to measure patient satisfaction with re-
mote monitoring of patients with CIED. This 30-item
questionnaire showed good reliability and validity to as-
sess satisfaction in patients implanted with all types of
CIED, suggesting that the questionnaire is valid across
different groups of patients. Patients who were naïve in
the use of CareLink® Network along with those who had
Fig. 1 Confirmatory Factor Analysis standardized solution
Table 3 Correlations among VALIOSA dimensions (rows) and visual analog scales (columns)
Dimension VAS Measure
Information Convenience Transmission Monitoring General Opinion
Disease Information .333** .258** .376** .376** .337**
Convenience .112 .478** .408* .306** .470**
Transmission .104 .405** .406** .323** .351*
Monitoring .206** .501** .504** .422** .534**
General Benefits .259** .463** .404** .486** .488**
HRQoL Health-related Quality of Life. Significance: * p < 0.05, ** p < 0.01
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more than 1 year of experience were included, and this
classification factor was not shown to have an influence
on the level of satisfaction, suggesting that the system is
well accepted from very early stages in its use. The level
of satisfaction of the study population was found to be
very high, with scores of more than 80 in all dimen-
sions. Initial results were reported at the 23rd Inter-
national Society for Quality Of Life Research Annual
Conference [25].
Study findings
Three items proved somewhat problematic. Item 8 (“It is
easy for me to make the transmission”), was initially pro-
posed as an indicator of the Transmission Process di-
mension, but it was ultimately better allocated to the
Convenience dimension, and cross-loading in both di-
mensions was proposed. Item 19 (“The fact that the con-
sultation is done at home instead of at the hospital is a
problem for me”), initially assigned to the Monitoring di-
mension, showed significant cross-loading with the Trans-
mission dimension. Item 14 (“Using the transmitter makes
me feel better cared for”), initially assigned to the Moni-
toring dimension, showed significant cross-loading with
the General Benefits dimension. Nevertheless, moving
these items to the dimensions they cross-load with does
not improve dimension reliability, suggesting they should
remain in their proposed dimensions pending on other
additional evidence. While the overall scale exhibited good
reliability, some individual subscales showed only accept-
able reliability when accounting for the multidimensional
structure, suggesting that they should be used isolated
with care.
The second order factor structure did fit our data
properly. Items (first order indicators) loaded with a sta-
tistically significant weight and most with a loading (in
absolute value) above 0.6. The exception was the rela-
tively low loading for items 9 and 10, which also showed
correlation between their error terms. This behavior
could be associated with a response bias for PM users,
since they transmit only once a year, and most did not
have the opportunity to experience any transmission
problem. First order dimension loadings on the Overall
Satisfaction second order dimension were all high and
had the expected sign, corroborating the high correlation
among all dimensions.
Correlations between dimension scores and conver-
gent VAS measures were as expected, although the
Health Monitoring dimension correlated more highly
with the Convenience and Transmission VAS measures.
These results may reflect the fact that some sites per-
form active patient monitoring, personally calling them
when any health problem needs to be addressed after
automatic transmissions (e.g. due to fluid retention).
This being the case, medical monitoring may affect the
Table 4 Correlation between VALIOSA dimensions and health-
related quality of life measures
Dimension SF-36 Component
Physical Mental HRQoL
Disease Info. .030 .263** .094
Convenience .110 .043 .088
Transmission −.006 −.036 .019
Monitoring .090 .043 .061
General Benefits .106 .035 .157*
Physical 1.000 .012 .550**
Mental .012 1.000 .272**
HRQoL .550** .273** 1.000
Mean 37.2 52.1 73.1
Standard Deviation 8.68 10.54 19.88
** p < 0.01, * p < 0.05
Fig. 2 VALIOSA mean dimension score by device type. Note: ICD=Implantable Cardioverter-Defibrillator, PM=Pacemaker, CRT=Cardiac
Resynchronization Therapy device.
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patient perception of the adequateness of the transmis-
sion process and the convenience of the monitoring sys-
tem. Furthermore, VAS measures were found to be less
sensitive to patient differences than dimension scores,
behaving as overly holistic measures.
Patient satisfaction, as measured by the VALIOSA ques-
tionnaire, was shown to have little relation to HRQoL,
supporting proper construct validity.
As for known group validity, the different dimensions
were shown to be able to discriminate between types of
patients. As expected, PM patients were less satisfied with
the monitoring system, and perhaps setting up the moni-
tor and making the transmission may even be a burden
for them, as we learned from the focus groups. This could
be explained because PM patients do not transmit regu-
larly as ICD and CRT patients do because of their medical
condition, and hence they might find transmission prob-
lems more often that decreases their level of satisfaction
with the follow up. The questionnaire dimensions were
shown to be sensitive to differences in patient manage-
ment at different sites, with lower satisfaction for those
patients treated more impersonally.
Benefits and applications of the VALIOSA questionnaire
The present patient satisfaction questionnaire could be-
come a useful instrument in quality-of-care assessment,
either being used by clinicians or hospital administra-
tions. In this way, this tool can be used to evaluate pa-
tient’s impressions of RM at different times at hospitals
and therefore benchmark between different healthcare
institutions. The success of telemedicine programs must
include patient’s perspectives to understand how well
they serve the needs and address the concerns of the pa-
tients. Therefore, investigating patients’ impressions with
accuracy and precision could help in the design and im-
plementation of telemedicine systems that can improve
the quality of healthcare delivery.
Limitations
Present results may not represent patients using other
RM systems without further study. The brand name of
the RM system was included in the questionnaire since
elder patients showed problems to differentiate between
the RM system and the CIED, but replacing the name of
the system used in the study with other names should
not be a problem. The questionnaire may be adapted to
other e-health monitoring systems but important par-
ticularities, such as web usability or time to response
could be missing. Adaptation to other RM systems may
need the inclusion of additional items when special
prophylactic measures are customary, such as continu-
ous glucose monitoring systems in insulin pumps for
diabetics. Items should be adapted for use of the
questionnaire in a telephone interview, since most of
them are written in first person.
Conclusions
In the last years, remote monitoring of patients implanted
with CIED has grown as an alternative to in-office follow-
up. Rigorous studies have demonstrated its clinical and
economic benefits to patients and healthcare institutions.
The VALIOSA questionnaire is the first validated ques-
tionnaire developed to assess patient satisfaction with RM
which has shown good reliability and validity. The ques-
tionnaire may be adapted to other cardiac RM systems by
changing the name of the system, although maintenance
of psychometric properties should be assessed.
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